Brief: Stenocare Announces Positive Outcome Of Feasibility Study

StenoCare A/S

17/01/2022 07:03

Jan 17 (Reuters) - Stenocare A/S  STENO.CO :
    * STENOCARE ANNOUNCES POSITIVE OUTCOME OF FEASIBILITY STUDY
    * STENOCARE A/S AND SOLURAL PHARMA HEREBY ANNOUNCE THAT THEY
HAVE
REACHED MILESTONE 1 IN RESEARCH AND DEVELOPMENT OF A NEW MEDICAL
CANNABIS OIL FORMULATION
    * MILESTONE IS REACHED IN A FEASIBILITY STUDY AND SHOWS THAT
SOLURAL PHARMA'S LYMPHATIC TARGETING TECHNOLOGY IS COMPATIBLE
WITH FULL SPECTRUM MEDICAL CANNABIS MATERIALS.

Source text for Eikon:  ID:nWkr6Pz77r 
Further company coverage:  STENO.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))